145 related articles for article (PubMed ID: 38421243)
21. Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic Review.
Weiner AB; Kakani P; Armstrong AJ; Bossi A; Cornford P; Feng F; Kanabur P; Karnes RJ; Mckay RR; Morgan TM; Schaeffer EM; Shore N; Tree AC; Spratt DE
Eur Urol; 2024 May; ():. PubMed ID: 38782697
[TBL] [Abstract][Full Text] [Related]
22. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
23. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
[TBL] [Abstract][Full Text] [Related]
24. Post-prostatectomy radiation therapy for locally recurrent prostate cancer.
Isharwal S; Stephenson AJ
Expert Rev Anticancer Ther; 2017 Nov; 17(11):1003-1012. PubMed ID: 28922958
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant and Salvage Radiation Therapy After Prostatectomy: ASTRO/AUA Guideline Amendment, Executive Summary 2018.
Pisansky TM; Thompson IM; Valicenti RK; D'Amico AV; Selvarajah S
Pract Radiat Oncol; 2019; 9(4):208-213. PubMed ID: 31051281
[TBL] [Abstract][Full Text] [Related]
26. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy.
Knipper S; Ascalone L; Ziegler B; Hohenhorst JL; Simon R; Berliner C; van Leeuwen FWB; van der Poel H; Giesel F; Graefen M; Eiber M; Heck MM; Horn T; Maurer T
Eur Urol; 2021 Apr; 79(4):537-544. PubMed ID: 33317857
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients.
Gandaglia G; Briganti A; Clarke N; Karnes RJ; Graefen M; Ost P; Zietman AL; Roach M
Eur Urol; 2017 Nov; 72(5):689-709. PubMed ID: 28189428
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.
Van den Broeck T; van den Bergh RCN; Arfi N; Gross T; Moris L; Briers E; Cumberbatch M; De Santis M; Tilki D; Fanti S; Fossati N; Gillessen S; Grummet JP; Henry AM; Lardas M; Liew M; Rouvière O; Pecanka J; Mason MD; Schoots IG; van Der Kwast TH; van Der Poel HG; Wiegel T; Willemse PM; Yuan Y; Lam TB; Cornford P; Mottet N
Eur Urol; 2019 Jun; 75(6):967-987. PubMed ID: 30342843
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines.
Valicenti RK; Thompson I; Albertsen P; Davis BJ; Goldenberg SL; Wolf JS; Sartor O; Klein E; Hahn C; Michalski J; Roach M; Faraday MM;
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):822-8. PubMed ID: 23845839
[TBL] [Abstract][Full Text] [Related]
30. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
Cookson MS; Aus G; Burnett AL; Canby-Hagino ED; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus SR; Moul JW; Tangen C; Thrasher JB; Thompson I
J Urol; 2007 Feb; 177(2):540-5. PubMed ID: 17222629
[TBL] [Abstract][Full Text] [Related]
31. ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer.
Dal Pra A; Dirix P; Khoo V; Carrie C; Cozzarini C; Fonteyne V; Ghadjar P; Gomez-Iturriaga A; Panebianco V; Zapatero A; Bossi A; Wiegel T
Clin Transl Radiat Oncol; 2023 Jul; 41():100638. PubMed ID: 37251620
[TBL] [Abstract][Full Text] [Related]
32. Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review.
Artibani W; Porcaro AB; De Marco V; Cerruto MA; Siracusano S
Urol Int; 2018; 100(3):251-262. PubMed ID: 29161715
[TBL] [Abstract][Full Text] [Related]
33. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant versus salvage radiotherapy following radical prostatectomy: do the AUA/ASTRO guidelines have all the answers?
Su MZ; Kneebone AB; Woo HH
Expert Rev Anticancer Ther; 2014 Nov; 14(11):1265-70. PubMed ID: 25367321
[TBL] [Abstract][Full Text] [Related]
35. Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy.
Stephenson AJ; Eastham JA
J Clin Oncol; 2005 Nov; 23(32):8198-203. PubMed ID: 16278473
[TBL] [Abstract][Full Text] [Related]
36. Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?
Ribeiro L; Stonier T; Stroman L; Tourinho-Barbosa R; Alghazo O; Winkler M; Dasgupta P; Popert R; Cathelineau X; Sanchez-Salas R; Murphy DG; Emberton M; Cathcart P
J Urol; 2021 Mar; 205(3):791-799. PubMed ID: 33021441
[TBL] [Abstract][Full Text] [Related]
37. Vesico-urethral anastomosis sampling: a forgotten tool for guiding salvage radiation after radical prostatectomy.
Timm B; Farag M; Liodakis P; Angus D; Lim Joon D; Bolton D
BJU Int; 2021 May; 127 Suppl 1():23-29. PubMed ID: 33973332
[TBL] [Abstract][Full Text] [Related]
38. Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited.
Vaidya A; Soloway MS
J Urol; 2000 Dec; 164(6):1998-2001. PubMed ID: 11061900
[TBL] [Abstract][Full Text] [Related]
39. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.
Moris L; Cumberbatch MG; Van den Broeck T; Gandaglia G; Fossati N; Kelly B; Pal R; Briers E; Cornford P; De Santis M; Fanti S; Gillessen S; Grummet JP; Henry AM; Lam TBL; Lardas M; Liew M; Mason MD; Omar MI; Rouvière O; Schoots IG; Tilki D; van den Bergh RCN; van Der Kwast TH; van Der Poel HG; Willemse PM; Yuan CY; Konety B; Dorff T; Jain S; Mottet N; Wiegel T
Eur Urol; 2020 May; 77(5):614-627. PubMed ID: 32146018
[TBL] [Abstract][Full Text] [Related]
40. Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation.
Ramsay CR; Adewuyi TE; Gray J; Hislop J; Shirley MD; Jayakody S; MacLennan G; Fraser C; MacLennan S; Brazzelli M; N'Dow J; Pickard R; Robertson C; Rothnie K; Rushton SP; Vale L; Lam TB
Health Technol Assess; 2015 Jul; 19(49):1-490. PubMed ID: 26140518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
